Insider Transactions in Q4 2021 at Immix Biopharma, Inc. (IMMX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2021
|
Carey Ng Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+2.38%
|
$125,000
$5.0 P/Share
|
|
Dec 20
2021
|
Carey Ng Director |
BUY
Conversion of derivative security
|
Indirect |
1,000,221
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.56%
|
$10,000
$5.0 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Conversion of derivative security
|
Indirect |
246,703
+41.65%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Conversion of derivative security
|
Direct |
74,116
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
3,000
+0.33%
|
$15,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+50.0%
|
$250,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Conversion of derivative security
|
Indirect |
3,915,913
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
2,500
+0.28%
|
$12,500
$5.0 P/Share
|
|
Dec 17
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
2,200
+0.24%
|
$8,800
$4.47 P/Share
|